Coating with SP94 peptide that specifically binds to GRP78, nanoparticles containing doxorubicin significantly reduced the sizes of prostate cancer xenografts in mice exposed to ultrasound real-time imaging [115]. Here, HSPA5 is linked to prostate cancer.